Covovax For 12-17 Age Group

New Delhi: The National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group. The government panel decided to include Covovax in India’s…